New York 2023-2024 Regular Session

New York Assembly Bill A10668

Introduced

7/22/24

Refer

7/22/24

Caption

Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product, including biological products.

Latest NY A10668 Activity

View All Events: NY 2023-2024 Regular Session A10668

Companion Bills

No companion bills found.

Previously Filed As

NY A04732

Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product, including biological products.

NY SB190

Relating to the prescription and pharmaceutical substitution of biological products.

NY HB542

Relating to the prescription and pharmaceutical substitution of biological products.

NY SB542

Relating to the prescription and pharmaceutical substitution of biological products.

NY HB117

Relative to the substitution of biological products.

NY HB1365

Relative to substitution of biological products by pharmacies.

NY SB00197

An Act Concerning Biological Products.

NY HB07118

An Act Concerning Biological Products.

NY SB00313

An Act Concerning Biological Products.

NY HB751

Relating to the prescription and pharmaceutical substitution of biological products; amending provisions subject to a criminal penalty.

Similar Bills

No similar bills found.